The exact mechanism by which Endothelin-1 (ET-1) and Angiotensin II (Ang II), and their antagonists act in physiology are controversial subjects among researchers. Therefore, the present study aimed to determine the effects of bosentan and losartan on oxidative stress and serum cortisol levels. The present design included two experiments. The first one contains four groups: Group 1 saline infusion, Group 2, ET-1 infusion, Group 3, Bosentan + ET-1, and Group 4, Losartan + ET-1. The second experiment includes: Group 1, Saline infusion, Group 2, Ang II infusion, Group 3, Losartan + Ang II, and Group 4, Bosentan + Ang II. The results from the experiment I demonstrated that bolus infusion of losartan significantly decreased serum cortisol, while bosentan slightly reduced it versus ET-1. Beside in experiment II, bosentan could significantly decrease cortisol compared with Ang II. Neither losartan nor Ang II changed serum cortisol significantly in comparison with Ang II and saline groups. Furthermore, bosentan caused rising in malondialdehyde (MDA) concentration compared to ET-1 infusion, but losartan slightly decreased it. MDA in Ang II infusion dramatically became high in comparison with saline infusion, and both losartan and bosentan non significantly returned it to the base line levels. Furthermore, serum glucose concentration clearly rose in losartan infusion, while bosentan did affect it significantly. Serum chloride in both bosentan and losartan significantly increased compared to ET-1. Both ET-1 and Ang II infusions for one hour led to increase Mg ++ concentration in concomitant with saline infusion, while bosentan and losartan did not change it as compared with ET-1 and Ang II, respectively. In conclusion: Both ET-1 and Ang II antagonists reduced cortisol levels, but they did not change lipid peroxidation marker as elevated by Ang II infusion. Interestingly, ET-1 and Ang II markedly could increase serum Mg ++ levels, but their antagonists did not return it to the normal levels. [Sarkawt Hamad Ameen Hamad; Ismail Mustafa Maulood; Almas MR Mahmud. Effect of Bosentan and Losartan on Oxidative Stress and Cortisol levels in Endothelin-1 and Angiotensin II Treated Rats. Life Sci J 2016;13(10):43-49].
Introduction
Steroids among them glucocorticoids contribute in many physiological changes such as disease, trauma, and toxins which are well responded by corticoids (Fernandes et al. 2008 ). The cortisol hormone which secrets in adrenal cortex play important roles in developing oxidative stress and increases free radical level (Mercanoglu et al. 2008) . While, there is little investigation about bosentan and losartan and their consequences on serum cortisol level and oxidative stress, but endothelin and angiotension II stimulate adrenocorticiod secretion (Rabano et al. 2004; Vierhapper et al. 1995) On the other hand, ET-1 is widely synthesized in endothelial cell, it is well known as a potent vasoconstrictor by constricting blood vessels strongly (Lin et al. 2014 ). ET-1 has two receptor sub types, ET-1 A which perform cell proliferation, vasoconstriction and many other physiological actions, thus through ET-1 B would facilitate vasodilation (Maguire and Davenport 2014) . For antagonizing ET-1 many synthetic antagonist have been produced to block single or dual ET-1 receptors, such as BQ123, BQ 788 and Bosentan, but only bosentan reach final step in pharmaceutical process, and used as a drug (Busnadiego et al. 2014 ). Bosentan is ET-1 A/B dual receptor antagonist which is used to treat pulmonary hypertension (Markova et al. 2013 ).
Furthermore, Ang II secrets in many tissues, but generally it produces from a precursor of angiotensin I by action of angiotensin converting enzyme. It has a variety of physiological functions through binding with two different types of Ang II receptors (Barrett et al. 2010) . Ang II subtype one receptor (AT 1 ) is responsible in enhancing cell proliferation, vasoconstriction, oxidative stress, production of other endocrine hormones, and increase Na + / K + pump activity (Lottermoser et al. 2003; Rabano et al. 2004; Seifi et al. 2014) . While, stimulation of Ang II subtype two receptor (AT 2 ) lead to vasodilation, pro apoptotic, anti-inflammation and anti-growth (Savoia et al. 2011 ). Thus, one of the most anti hypertension drug is losartan, it could attenuate Ang II hypertensive effects through antagonizing AT 1 receptor (Shiga et al. 2014 ).
Because of, the interactions between ET-1 and Ang II, and their antagonist actions on the body organs are the most controversial subjects among researchers, therefore the present work is to investigate, the effects of bosentan and losartan on oxidative stress and serum cortisol levels.
Materials and Methods Animals
Albino rats (Rattus norvegicus ) were bred in the animal house that belongs to Biology department, College of Science, Salahaddin University-Erbil. Forty-two male rats weighs between 300 -400 grams have been used (six rats were kept for each plastic cage), overnight fasted (8) (9) (10) (11) (12) hr and animals were brought to the laboratory at the day of surgery. They were allowed to free access of tap water ad libitum Anesthesia and control of the body temperature
The animals were anesthetized by intraperitonial injection of a mixture of Ketamine hydrochloride 80 mg / Kg (Trittau, Germany) and Xylazin 12 mg / Kg (Interchem, Holland). The depth of anesthesia was monitored by loosing reflexes. The anesthesia was remained for 1.5 -2 hours and a supplement dose was used if necessary. The maximum volume anesthesia solution was 1ml / Kg; Rat's body temperature was controlled by placing on an electrical heating pad between 35 -37 o C.
Procedure for tracheostomy
Tracheostomy was performed in order to achieve good ventilation and avoiding bronchial obstruction. Sterile forceps were used to pull up neck skin in the middle, and about 2 -3 cm incision was made longitudinally; layers of the neck skin were removed and cleaned from the connective tissue, the platysma muscle was dissected to observe trachea. Fine iris scissors were used to slit incision of the ventral part of trachea, it must be managed as fast as possible to prevent rat from bleeding and hypoxia, then polythene tube 2 mm OD, 4-5 cm was inserted and was tightened by ligature, for prevention of clot inside the tube it was wetted by heparinized normal saline 10 IU/ml. a syringe connected to a PE tube (ID 0.58 mm, OD 0.96 mm. England) had been used to control bronchial secretion, so any solutions present in the trachea removed by it.
Cannualation of femoral vein for intravenous infusion
Concave sterile scissors were used for making a small incision 2 -3 cm on the right thigh, the outer layer of skin and matrix of collagen fibers had been removed, and cleaned carefully; a transient obstruction of blood back flow to the heart, it made the vein quite prominent, then a 27 G ½ needle filled with heparinized normal saline 10 IU / ml was inserted into the vessel which was attached to the polythene tube (ID 0.58 mm, OD 0.96 mm. England), that was connected to infusion pump (Advance series 1200 infusion system, USA). Through a 10 ml sized syringe, immediately after insertion of cannula normal saline was infused (15 ml / h /Kg). The administration of normal saline continued for hour, it called equilibration period, then the experimental design conducted; the wound was kept moisture by covered a gauze with heparinized normal saline.
Design of the experiments
The experimental design includes two sub experiments: Experiment A consisted of four groups, Group1, Saline ( n = 6 ) animals were infused with normal saline (15 ml / h/ Kg) after equilibration period, Group 2, Endothelin-1 (n = 6) animals were infused with ET-1 (520 ng / min/ Kg), Group 3, Bosentan + Endothelin-1 (n = 6) the rats were infused bolus infusion of bosentan 10 mg/ 0.5ml / kg then continuously animals infused ET-1 (520 ng / min / Kg), and Group 4, Losartan + Endothelin-1 (n = 6) the rats were infused bolus infusion of losartan 10 mg/ 0.5 ml / kg then continuously animals infused ET-1 (520 ng / min/ Kg). Experiment B also consisted of four goups, Group 1, saline and treated as in experiment A, Group 2, Angiotensin II (n = 6) animals were infused Ang II (320 ng / min / Kg), Group 3, Losartan + Angiotensin II (n = 6) the rats were infused bolus infusion of losartan 10 mg/ 0.5 ml / kg then continuously animals infused Ang II (320 ng / min / Kg), and Group 4 Bosentan + Angiotensin II (n = 6) the rats were infused bolus infusion of bosentan 10 mg/ 0.5ml / kg then continuously animals infused with Ang II (320 ng / min / Kg).
Collection of blood samples
At the end of the sixty minutes of infusion about 7 ml of blood were obtained, through puncturing of heart, then standing in a clean clot activator gel test tube for 30 minutes; the blood centrifuged at 1000 g for 15 minute (Centromix-Mod. S-549), then serum was transferred into four clean eppendorf tubes and they were stored at -80 o C until assay (Sanyo -Ultra -Low Temperature, Japan).
Determination of serum cortisol
Enzyme immunosorbent assay( ELISA) method was used for determination of serum cortisol. The essential reagents required for an enzyme immunoassay include antibody, enzyme-antigen conjugate and native antigen. Upon mixing biotinylated antibody, enzyme-antigen conjugate and a serum containing the native antigen, a competition reaction results between the native antigen and the enzyme-antigen conjugate for limited number of antibody sites.
Determination of serum MDA
An MDA-(Thiobarbituric acid )TBA was used to determine serum MDA, serum sample 150 µL and 1ml of 17.5% Trichloacetic acid (TCA) were added into clean centrifuge test tube (Supe-Rior, W-Germany), TCA was allowed to deproteinize specimen. One ml of 0.66% TBA added into same tube and it was mixed well by vortex (Vortex-Genie, Model K-550-Ge, USA). The sample was allowed for boiling at 95 o C in the water bath (Memmert, Gmbh+Co. KG, Germany) for a period of 45 minutes and left at room temperature 25 o C to cool, then 1 ml of 70% TCA added to precipitate the ruminant serum protein, centrifuged (Centromix-Mod. S-549) at 1000 g for 15 min, the pink colour indicate reaction was occurred, then read at 532 nm by spectrophotometer (Apel-PD303-Japan).
Determination of serum glucose
Oxidation of glucose was determined by enzymatic reactions using (Randox) kit. It produced a violet quinoneimine coluor absorbed by spectrophotometer (500 nm) which was proportioned to glucose concentration.
Determination of serum chloride
BioLabo (France) kit method was used to determine serum chloride by using spectrophotometer (Apel-PD303-Japab).
Determination of serum magnesium
Gindler, Heth and Khayam-Bashi method was used for determination of magnesium. The BioLabo (France) kit method was used to determine serum magnesium by using spectrophotometer (Apel-PD303-Japab).
Results
In the experiment A, bolus infusion of losartan significantly (P < 0.05) decreased serum cortisol level as compared with ET-1 group, while bosentan reduced cortisol level but it did not reach statistical consideration. There was no statistical difference between ET-1 and saline group (Figure 1, A) . Beside that, in the experiment B, bosentan could significantly decrease cortisol level versus Ang II. Neither losartan nor Ang II changed serum cortisol significantly in comparison with Ang II and saline groups, respectively (Figure 1, B) .
On the other hand, bosentan raised MDA concentration after ET-1 infusion (P < 0.05), but losartan slightly decreased it (Figure 2, A) . MDA in Ang II infusion dramatically became high in comparison with saline infusion while, both losartan and bosentan non significantly returned it to the base line levels (Figure 2, B ).
Figure 1: Serum cortisol in A, ET-1 treated rats. B, Ang II treated rats.
The different letters mean significant and the same letters mean no significant differences. The data mean ± SEM, P < 0.05 consider a significant difference according to 1-way ANOVA followed by Duncan post hoc test.
Figure 2: Serum MDA (µg/dL) in A, ET-1 treated rats. B, Ang II treated rats.
The different letters mean significant and the same letters mean no significant differences. The data mean ± SEM, P < 0.05 consider a significant difference according to 1-way ANOVA followed by Duncan post hoc test. The different letters mean significant and the same letters mean no significant differences. The data mean ± SEM * P < 0.05 considered a significant difference according to 1-way ANOVA followed by Duncan post hoc test. Table 2 shows that, Mg ++ was increased in bosentan (0.308 ± 0.040) and it was decreased in losartan (0.261 ± 0.044) as compared with Ang II (0.296 ± 0.025), but only bosentan could increases chloride (P < 0.05). There was no statistical change in glucose concentration in experimental B.
The different letters mean significant and the same letters mean no significant differences. The data mean ± SEM * P < 0.05 considered a significant difference according to 1-way ANOVA followed by Duncan post hoc test.
Discussion
The present study demonstrates that both ET-1 A/B dual (bosentan) and Ang II AT 1 (losartan) receptors attenuates cortisol concentration, have roles in oxidative stress and magnesium regulation, also bolus infusion of them affected chloride ion and glucose homeostasis. Losartan bolus infusion could reduce serum cortisol significantly as compared with ET-1infusion for one hour (Figure 1, A) . Additionally, bosentan markedly decreased the elevated cortisol concentration caused by Ang II infusion (Figure 1, B) . The exact mechanism by which losartan and bosentan caused cortisol reduction is not fully understood yet. However, our data agree with (Ansurudeen et al. 2014 ) which demonstrated that Ang II causes an increase in cortisol production. (Paramonova et al. 2010 ) reported that ET-1 causes proliferation of adrenocortical cells and promotes cortisol secretion. Furthermore, hyepercortisolemia has related with elevated ET-1 levels (Lederbogen et al. 1999) . Our data disagree with (le Mevel et al. 1999 ) who demonstrated that intra-arterial injection of ET-1 did not markedly modify cortisol levels. Also, (Vierhapper et al. 1995) concluded that cortisol concentration was unchanged by infusion of ET-1. Experimental data for reducing cortisol levels by bolus infusion of the losartan are limited, while a study observed that Ang II modulated transcription regulatory genes of cortisol secretion and expression levels of unique enzymes of the glucocorticoid biosynthesis pathways (Rondon et al. 2014) In addition, Ang II directly stimulates adrenal cortisol production through releasing nitric oxide (Gauthier et al. 2005) .
Although, ET-1 slightly elevated lipid peroxidation through serum MDA levels ( Figure 2, A  and B) , while, Ang II increased it significantly as compared with the saline infusion. Interestingly, Bosentan infusion markedly increased MDA levels, whereas Losartan infusion did not change it significantly. It has been reported that the Ang II infusion (Bild et al. 2013; Dianat et al. 2014 ) and ET-1 infusion would increase oxidative stress and alters the balance between oxidant (MDA level) and antioxidant enzymes (Fiore et al. 2005) , and more recently (Lankhorst et al. 2014 ) demonstrated that activation of the ET-1 axis induces oxidative stress. However, at present there is no exact explanation for MDA elevation by bosentan administration, but a report indicated that, bosentan enhances hepatic toxicity and liver damage (Eriksson et al. 2011 ). Additionally, free radical production is strongly related with glucose metabolism, hence there is a report demonstrated that bosentan affects liver glycogen content and serum glucose (Said et al. 2005) , however, our data is in contrast to (Demirci et al. 2015) who recently concluded that bosentan treatment improves diabetes -induces liver damage via oxidative stress reduction. Beside that, ET-1 infusion did not change serum glucose (Table 1) , and the result may be due to ET-1 induces glucose uptake Bolus infusion of both losartan and bosentan slightly increased serum chloride as compared with ET-1 infusion ( Table 1 ). The possible mechanisms may be returned to inhibition of Na + -K + -2Clcotransporter and Cl -/ HCO 3 exchanger (Dai and Zhang 2004). On the other hand, ET-1 inhibits thick ascending limb chloride flux via ET B receptor mediated NO release (Plato et al. 2000) , and ET-1 can potently stimulate chloride secretion (Kuhn et al. 1997) .
Magnesium is an important physiological intracellular ion which has roles in cardiovascular regulation and it relaxes vessels and hence reduce blood pressure. (Finckenberg et al. 2005; Rondon et al. 2014 ). The present study (Table 1, and 2) showed that both ET-1 and Ang II infusion for one hours significantly increased serum magnesium. However, there is no previous report indicating such relation between magnesium ions and ET-1 and Ang II actions. However, many studies have been reported that magnesium ameliorate Ang II and ET-1 production (Berthon et al. 2003; Berthon et al. 2002; Ozturk et al. 2012) . Although, Ang II infusion induced hypermagnesiuria, and hence reduces magnesium ions (Wu and Sonnenberg 1995), both ET-1 and Ang II increased magnesium, it is believed that this due to glomerular filtration rat (GFR) reduction and no more magnesium could be excreted through the urine but the exact explanation for this result needs further confirmation. In conclusions, both losartan and bosentan could reduce cortisol levels, and bosentan rather than losartan can elevate oxidative stress, also Ang II infusion could rise MDA levels more than ET-1 infusion. Interestingly, both ET-1 and Ang II can markedly elevate serum magnesium levels.
